Post

New Preprint: Chloramphenicol in Wastewater โ€” Separating the Antibiotic at Source with ARBOK-PHARMIX

๐Ÿ’Š New preprint: Chloramphenicol in Wastewater โ€” Separating the Antibiotic at Source with ARBOK-PHARMIX Chloramphenicol is banned in food animals in the EU since 1994, yet it keeps appearing in surface water and pharmaceutical effluent. Conventional…

๐Ÿ’Š New preprint: Chloramphenicol in Wastewater โ€” Separating the Antibiotic at Source with ARBOK-PHARMIX

Chloramphenicol is banned in food animals in the EU since 1994, yet it keeps appearing in surface water and pharmaceutical effluent. Conventional treatment dilutes antibiotics in water or converts them into by-products of unknown toxicity: a recent electrochemical study removed chloramphenicol in 48 hours but left eight breakdown products. The preprint describes separation at source under deep vacuum at ambient temperature (ARBOK-PHARMIX): light molecules pass to vapor, antibiotics and other APIs settle as a concentrate split into dry salts, metals and acids, and more than 99.9% of the water returns to production. Energy use is 0.7 kWh per mยณ against 150โ€“250 kWh per tonne for evaporative ZLD. For a 500 mยณ-a-day plant, full operating cost with amortization is USD 120,000โ€“200,000 a year against USD 5.5โ€“9 million for current practice.

Authors: Michael Vischmidt, Dmitry Ponomarenko (ARBOK Strategic Research Institute).

DOI: 10.5281/zenodo.23977100

ResearchGate: Chloramphenicol in Wastewater: Separating the Antibiotic at Source with ARBOK-PHARMIX